Upgrade to SI Premium - Free Trial

Quest Diagnostics (DGX) PT Raised to $230 at Barclays

April 21, 2026 4:00 PM
Barclays analyst Luke Sergott raised the price target on Quest Diagnostics (NYSE: DGX) to $230.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change